of Chinese tourists in the past nine months of 2017, the number grew only by 1.1 percent when compared to the same period in the previous year; the amount in the third quarter was highly recovered from
Indorama Ventures Public Company Limited for the first quarter ended March 31, 2021 We are pleased to submit: 1. Consolidated and Company only Quarterly Review of Financial Statements for the first quarter
marketing strategy, OSP market share was maintained at 53.5%, aligned with our mid-term guidance. In Functional drinks market, C-Vitt, now a No.1 brand, strongly drove the market to grow by 19.3% YoY. At the
with all reasons above, it drove net profit to perform at THB 494 million or increased by 29.69% from 2Q2016. The EPS of 2Q2017 was THB 0.39 per share; which reflected another strong performance of GFPT
Expenses 31.25 35.24 (3.99) (11.13) Net Profit (Loss) (59.03) 58.74 (117.77) (200.49) Earnings per share (Baht per share) (0.05) 0.05 (0.10) (200.00) Net Profit The company and subsidiaries realized net loss
Administration Expenses 31.25 35.23 (3.98) (11.30) Net Profit (Loss) (59.03) 58.74 (117.77) (200.49) Earnings per share (Baht per share) (0.05) 0.05 (0.10) (200.00) Net Profit The company and subsidiaries realized
only at BKK and DMK Total revenue of Q3/2019 of the Group was Bt957.1 million increased by Bt16.6 million or 1.8%(y-o-y) and the services income was of Bt939.0 million increased by Bt10.1 million or 1.1
flights that serviced by BAFS only at BKK and DMK Total revenue of 2017 of the Group was Bt3,640.2 million decreased by Bt71.3 million or 1.9% compared with Bt3,711.5 million of 2016. While the services
be a potential market in the future. For Medical Devices; There is still intense competition in both domestic and foreign markets. Market leaders use price strategies to gain market share. But the
Flights was data of flights that serviced by BAFS only at BKK and DMK Page 2 of 8 Total revenue of Q2/2019 of the Group was Bt949.0 million increased by Bt23.5 million or 2.5%(y-o-y) and the services income